Global signal peptide profiling reveals principles of selective Sec61 inhibition

Shao, S. & Hegde, R. S. Membrane protein insertion at the endoplasmic reticulum. Annu. Rev. Cell Dev. Biol. 27, 25–56 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Egea, P. F., Stroud, R. M. & Walter, P. Targeting proteins to membranes: structure of the signal recognition particle. Curr. Opin. Struct. Biol. 15, 213–220 (2005).

Article  CAS  PubMed  Google Scholar 

Voorhees, R. M. & Hegde, R. S. Toward a structural understanding of co-translational protein translocation. Curr. Opin. Cell Biol. 41, 91–99 (2016).

Article  CAS  PubMed  Google Scholar 

Rapoport, T. A., Li, L. & Park, E. Structural and mechanistic insights into protein translocation. Annu. Rev. Cell Dev. Biol. 33, 369–390 (2017).

Article  CAS  PubMed  Google Scholar 

Liaci, A. M. et al. Structure of the human signal peptidase complex reveals the determinants for signal peptide cleavage. Mol. Cell. 81, 3934–3948 (2021).

Article  CAS  PubMed  Google Scholar 

Blobel, G. & Dobberstein, B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J. Cell Biol. 67, 835–851 (1975).

Article  CAS  PubMed  Google Scholar 

Von Heijne, G. Signal sequences: the limits of variation. J. Mol. Biol. 184, 99–105 (1985).

Article  Google Scholar 

Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40, 1023–1025 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nielsen, H., Tsirigos, K. D., Brunak, S. & von Heijne, G. A brief history of protein sorting prediction. Protein J. 38, 200–216 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voorhees, R. M. & Hegde, R. S. Structure of the Sec61 channel opened by a signal sequence. Science 351, 88–91 (2016).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hegde, R. S. & Kang, S. W. The concept of translocational regulation. J. Cell Biol. 182, 225–232 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Besemer, J. et al. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 436, 290–293 (2005).

Article  ADS  CAS  PubMed  Google Scholar 

Garrison, J. L., Kunkel, E. J., Hegde, R. S. & Taunton, J. A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature 436, 285–289 (2005).

Article  ADS  CAS  PubMed  Google Scholar 

Meyer, L. K. et al. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukemia. Br. J. Haematol. 198, 137–141 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rehan, S. et al. Signal peptide mimicry primes Sec61 for client-selective inhibition. Nat. Chem. Biol. 19, 1054–1062 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacKinnon, A. L., Garrison, J. L., Hegde, R. S. & Taunton, J. Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocation. J. Am. Chem. Soc. 129, 14560–14561 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maifeld, S. V. et al. Secretory protein profiling reveals TNF-α inactivation by selective and promiscuous sec61 modulators. Chem. Biol. 18, 1082–1088 (2011).

Article  CAS  PubMed  Google Scholar 

Mackinnon, A. L. et al. An allosteric Sec61 inhibitor traps nascent transmembrane helices at the lateral gate. eLife 3, e01483 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Harant, H. et al. The translocation inhibitor CAM741 interferes with vascular cell adhesion molecule 1 signal peptide insertion at the translocon. J. Biol. Chem. 281, 30492–30502 (2006).

Article  CAS  PubMed  Google Scholar 

Harant, H. et al. Inhibition of vascular endothelial growth factor cotranslational translocation by the cyclopeptolide CAM741. Mol. Pharmacol. 71, 1657–1665 (2007).

Article  CAS  PubMed  Google Scholar 

Itskanov, S. et al. A common mechanism of Sec61 translocon inhibition by small molecules. Nat. Chem. Biol. 19, 1063–1071 (2023).

Article  CAS  PubMed  Google Scholar 

Ruiz-Saenz, A. et al. Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum. Oncogene 34, 5288–5294 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jura, N., Shan, Y., Cao, X., Shaw, D. E. & Kuriyan, J. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc. Natl Acad. Sci. USA 106, 21608–21613 (2009).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Baselga, J. & Swain, S. M. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9, 463–475 (2009).

Article  CAS  PubMed  Google Scholar 

Soltoff, S. P., Carraway, K. L., Prigent, S. A., Gullick, W. G. & Cantley, L. C. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550–3558 (1994).

CAS  PubMed  PubMed Central  Google Scholar 

Wang, Z. et al. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nat. Commun. 12, 2383 (2021).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wilson, T. R., Lee, D. Y., Berry, L., Shames, D. S. & Settleman, J. Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers. Cancer Cell 20, 158–172 (2011).

Article  CAS  PubMed  Google Scholar 

Ogbechi, J. et al. Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4. Cell Death Dis. 9, 397 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Domenger, A. et al. The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. EMBO Mol. Med. 14, e14740 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drilon, A. et al. Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers. Cancer Discov. 8, 686–695 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan, H. K. et al. A phase I, first-in-human study of GSK2849330, an anti-HER3 monoclonal antibody, in HER3-expressing solid tumors. Oncologist 26, e1844–e1853 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devaraneni, P. K. et al. Stepwise insertion and inversion of a type II signal anchor sequence in the ribosome-Sec61 translocon complex. Cell 146, 134–147 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vermeire, K. et al. Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation. PLoS Biol. 12, e1002011 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Chitwood, P. J., Juszkiewicz, S., Guna, A., Shao, S. & Hegde, R. S. EMC is required to initiate accurate membrane protein topogenesis. Cell 175, 1507–1519 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, 1–20 (2016).

Article  Google Scholar 

Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011).

留言 (0)

沒有登入
gif